Why Do You Feel Cold on a GLP-1? Body Temperature, Metabolic Adaptation, and What Microdosing Changes

Somewhere around the second month, a lot of people on semaglutide or tirzepatide start wearing a jumper indoors in weather that never bothered them before.

The complaint is everywhere in patient forums and clinic notes. Cold hands, cold feet, a partner who keeps asking why the thermostat has gone up two degrees. Yet cold intolerance does not appear among the common side effects on either drug's label, and the big trials did not flag it.

The explanation sits mostly in basic physiology rather than in anything unusual about GLP-1 medicines. This article covers where body heat comes from, what happens to it when intake drops by a quarter, what the Minnesota Starvation Experiment and the Leibel weight clamp studies showed about metabolic adaptation, which lab problems can make someone feel cold for other reasons, and where a lower dose protocol fits.

Is feeling cold a side effect of GLP-1 medications?

Common in practice, absent from the label

Feeling cold is not a recognised side effect of GLP-1 medications in the prescribing information, but it is a common experience during GLP-1 weight loss. The adverse reaction tables for semaglutide and tirzepatide are dominated by nausea, diarrhoea, vomiting, constipation, and abdominal pain. Chills and cold intolerance do not appear among the frequent events in the STEP or SURMOUNT programmes.

The gap between the label and lived experience has a simple explanation. Trials record symptoms that happen more often on the drug than on placebo, and placebo participants in weight trials lost far less weight. A symptom caused by eating less and losing weight quickly would show up as a mild, diffuse complaint that few people report to a trial nurse. It would also appear in anyone losing weight fast by other means, which is what the older diet research shows.

Where does body heat come from?

Every calorie burned ends up as heat

Body heat comes from metabolism, so almost every calorie the body burns is eventually released as heat. Resting metabolism, the energy used by the organs, brain, and muscle at rest, accounts for roughly 60 to 70 percent of daily energy use in most adults. Digesting and storing food, called the thermic effect of food, accounts for about 10 percent. Movement makes up the rest, from exercise to fidgeting and walking around the house.

A GLP-1 medication can trim all three at once. Smaller meals mean less heat from digestion. Resting metabolism falls as body mass falls. Many people also move a little less during a deficit without noticing, which the NEAT article on this site covers in more detail. None of these changes is large alone, but together they reduce the heat the body produces each day.

How much less do people eat on semaglutide?

About a quarter less at full dose

People on a full dose of semaglutide eat roughly a quarter less than they would on placebo. John Blundell and colleagues at the University of Leeds tested this directly in a crossover study of 30 adults with obesity, published in Diabetes, Obesity and Metabolism in 2017. After 12 weeks on semaglutide 1.0 mg weekly, total ad libitum energy intake across a test day was about 24 percent lower than after placebo, with less hunger, fewer cravings, and a lower preference for fatty foods.

The same study found that resting metabolic rate, once adjusted for body composition, was not significantly different between the two treatments. That result points away from semaglutide switching off heat production directly. The drop in intake, and the weight loss that follows, carry most of the explanation.

Does the body burn less energy after weight loss?

Yes, and by more than body size explains

The body burns less energy after weight loss, and the drop is larger than the smaller body alone would predict. Rudolph Leibel, Michael Rosenbaum, and Jules Hirsch at Rockefeller University showed this in a classic 1995 study in the New England Journal of Medicine. Adults who were held at 10 percent below their usual weight had total daily energy expenditure about 15 percent lower than expected for their new size and composition. Those held at 10 percent above their usual weight burned about 16 percent more.

Later work by Rosenbaum and Leibel linked much of this adaptation to the fall in leptin that follows fat loss. Lower leptin was accompanied by lower active thyroid hormone and reduced sympathetic nervous system activity, and giving leptin back partly reversed those changes. A lower thyroid and sympathetic tone means less heat production and more constriction of blood vessels in the skin, which is the same pattern people describe as cold hands and cold feet. The metabolic adaptation article on this site goes further into resting metabolic rate on GLP-1s.

What did the Minnesota Starvation Experiment show about feeling cold?

The extreme end of the same response

The Minnesota Starvation Experiment showed that cold intolerance is one of the most consistent effects of prolonged underfeeding. Ancel Keys and colleagues fed 32 healthy young men about 1,570 kcal per day for 24 weeks during 1944 and 1945, and published the results in 1950. The men lost about a quarter of their body weight. They complained constantly of feeling cold, even in summer, and many wore extra layers indoors.

Basal metabolic rate fell from roughly 1,590 to about 965 kcal per day, a drop of close to 40 percent. Heart rate and body temperature also fell. When the men were refed, the cold sensitivity faded along with the other symptoms.

Nobody on a supervised GLP-1 protocol should be anywhere near this degree of restriction. The study is useful because it shows the direction of the response clearly. Feeling cold is the body conserving heat when fuel is scarce, and the size of the effect scales with how hard the deficit pushes.

Does moderate calorie restriction lower body temperature?

Slightly, in the one trial that measured it well

Moderate calorie restriction lowers core body temperature by a small amount. Leonie Heilbronn and colleagues at the Pennington Biomedical Research Center reported in JAMA in 2006 on the first CALERIE trial, which randomized 48 overweight adults to six months of calorie restriction, restriction plus exercise, a very low calorie diet, or control. Calorie restriction lowered core body temperature, fasting insulin, and 24 hour energy expenditure, and energy expenditure fell by more than the weight loss explained.

Lost fat adds to the effect in a separate way. Subcutaneous fat is an insulating layer, so people who lose a lot of it lose some protection against heat loss from the skin. This matters most in the hands, feet, and thighs, and it is one reason cold sensitivity can linger for a while after weight loss has levelled off.

Do GLP-1 drugs affect brown fat?

Yes in rodents, not clearly in people

GLP-1 drugs increase brown fat heat production in rodents, but human studies have not shown a meaningful rise in heat output. Lockie and colleagues reported in Diabetes in 2012 that GLP-1 receptor activation in the mouse brain switched on brown adipose tissue thermogenesis through the sympathetic nervous system. If that held in people, GLP-1 drugs would, if anything, warm the body up.

A 2020 study by Janssen and colleagues in the journal Metabolism gave exenatide or placebo to men without diabetes for 12 weeks and measured brown fat on PET scans. Exenatide raised glucose uptake into brown fat, but resting energy expenditure did not change. Small rodents rely far more on brown fat for warmth than adult humans do, so the animal result does little to offset the heat lost from eating less.

When does feeling cold usually start and ease on a GLP-1?

It tends to follow the steepest part of the deficit

Feeling cold on a GLP-1 tends to build over the first two to three months and ease once weight loss slows. That pattern fits the physiology. The deficit is usually largest after dose escalation, when appetite is most suppressed and weekly weight loss is fastest. As weight approaches a new plateau and eating settles, the adaptive drop in heat production narrows.

No trial has tracked cold sensitivity week by week on a GLP-1, so the chart below is a model rather than data. It is still a useful way to think about the question. Cold sensitivity seems to follow the size of the deficit more than the dose on the syringe.

What else can make you feel cold during GLP-1 weight loss?

Causes worth ruling out

Several medical problems cause cold intolerance on their own, and some become more likely when someone is eating much less. Strong, persistent, or worsening cold sensitivity is a reason to see a clinician rather than to assume it is just the deficit. The micronutrient and thyroid articles on this site go into these in more depth.

Does a microdose protocol cause less cold sensitivity?

Plausible, not tested

No study has compared cold sensitivity between microdose and full dose GLP-1 protocols, so any difference is a hypothesis. The reasoning is straightforward. If feeling cold is driven mainly by the size of the calorie deficit and the speed of weight loss, a lower dose that suppresses appetite less and produces slower loss would be expected to cause less of it.

The same logic applies to fatigue, hair shedding, and muscle loss, which also scale with how steep the deficit is. The practical points below are worth discussing with a healthcare provider, whatever the dose.

What is still unknown about GLP-1 medicines and body temperature?

Gaps worth naming

The biggest gap is that no GLP-1 trial has measured core body temperature or cold sensitivity as an outcome. Everything in this article about the link comes from calorie restriction research, general physiology, and patient reports. A trial that simply asked participants to rate cold sensitivity alongside weight and intake would settle much of the question.

Tirzepatide adds another unknown. Its GIP component acts on fat tissue, and whether that changes thermoregulation differently from semaglutide has not been studied in people. Dose is the third gap. All of the intake and energy expenditure data here come from full doses or from diet studies, not from microdose protocols.

Frequently Asked Questions